14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Blueprint Medicines Corporation Stock Forecast

NASDAQ:BPMC BUY SELL

$56.21 (2.29%)

Volume: 390.668k

Closed: May 16, 2022

Hollow Logo Score: -3.633

Blueprint Medicines Corporation Stock Forecast

BUY SELL NASDAQ:BPMC
$56.21 (2.29%)

Volume: 390.668k

Closed: May 16, 2022

Score Hollow Logo -3.633

Blueprint Medicines Corporation Stock Forecast NASDAQ:BPMC

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-04-13 20.97% Citigroup $71.00 $68.00 Maintains Neutral
2022-03-04 86.8% Stifel $100.00 $105.00 Maintains Buy
2022-03-01 - Citigroup - Initiates Coverage On Neutral
2022-02-17 77.9% HC Wainwright & Co. $135.00 $100.00 Maintains Buy
2022-02-17 45.88% SVB Leerink $93.00 $82.00 Downgrades Outperform Market Perform
2022-02-01 63.67% Morgan Stanley $111.00 $92.00 Maintains Equal-Weight
2022-01-25 69.01% Stifel $120.00 $95.00 Upgrades Hold Buy
2022-01-12 113.49% SVB Leerink $132.00 $120.00 Maintains Outperform
2021-11-10 136.61% Raymond James $122.00 $133.00 Maintains Strong Buy
2021-10-29 97.47% Morgan Stanley $96.00 $111.00 Maintains Equal-Weight
2021-07-30 70.79% Morgan Stanley $101.00 $96.00 Maintains Equal-Weight
2021-06-17 118.82% Baird $119.00 $123.00 Maintains Outperform
2021-06-17 143.73% SVB Leerink $127.00 $137.00 Maintains Outperform
2021-06-17 131.28% Wedbush $136.00 $130.00 Maintains Outperform
2021-04-30 79.68% Morgan Stanley $105.00 $101.00 Maintains Equal-Weight
2021-04-13 141.95% Wedbush $119.00 $136.00 Maintains Outperform
2021-03-31 77.9% Credit Suisse $100.00 Initiates Coverage On Neutral
2021-02-18 69.01% Barclays $90.00 $95.00 Maintains Equal-Weight
2021-02-18 86.8% Morgan Stanley $112.00 $105.00 Maintains Equal-Weight
2021-01-12 125.94% SVB Leerink $121.00 $127.00 Maintains Outperform
2020-12-03 95.69% Stifel $110.00 Initiates Coverage On Hold
2020-11-02 70.79% Jefferies $96.00 Downgrades Buy Hold
2020-10-30 - Morgan Stanley - Downgrades Overweight Equal-Weight
2020-10-16 117.04% Raymond James $106.00 $122.00 Maintains Strong Buy
2020-10-13 77.9% Morgan Stanley $92.00 $100.00 Maintains Overweight
2020-07-27 90.36% SVB Leerink $106.00 $107.00 Maintains Outperform
2020-07-15 63.67% Morgan Stanley $88.00 $92.00 Maintains Overweight
2020-07-15 95.69% HC Wainwright & Co. $66.00 $110.00 Maintains Buy
2020-07-15 88.58% SVB Leerink $105.00 $106.00 Maintains Outperform
2020-06-08 51.22% Deutsche Bank $70.00 $85.00 Maintains Buy
2020-05-05 4.96% Barclays $59.00 Initiates Coverage On Equal-Weight
2020-04-30 56.56% Morgan Stanley $103.00 $88.00 Maintains Overweight
2020-04-30 77.9% Canaccord Genuity $115.00 $100.00 Maintains Buy
2020-04-29 33.43% BMO Capital $89.00 $75.00 Maintains Outperform
2020-04-29 17.42% HC Wainwright & Co. $100.00 $66.00 Reiterates Buy
2020-04-29 86.8% SVB Leerink $125.00 $105.00 Maintains Outperform
2020-04-29 83.24% JMP Securities $107.00 $103.00 Maintains Market Outperform
2020-03-17 58.33% BMO Capital $74.00 $89.00 Upgrades Market Perform Outperform
2020-03-17 24.53% Deutsche Bank $70.00 Upgrades Hold Buy
2020-02-18 83.24% Morgan Stanley $108.00 $103.00 Maintains Overweight
2020-01-28 31.65% BMO Capital $74.00 Initiates Coverage On Market Perform
2019-12-10 24.53% Deutsche Bank $75.00 $70.00 Maintains Hold
2019-11-06 92.14% Morgan Stanley $109.00 $108.00 Maintains Overweight
2019-11-06 - Raymond James - Upgrades Outperform Strong Buy
2019-10-29 33.43% Deutsche Bank $110.00 $75.00 Downgrades Buy Hold
2019-10-11 93.92% Morgan Stanley $110.00 $109.00 Maintains Overweight
2019-10-03 77.9% HC Wainwright & Co. $100.00 Initiates Coverage On Buy
2019-09-12 - Raymond James - Upgrades Market Perform Outperform
2019-08-29 51.22% Piper Sandler $85.00 Initiates Coverage On Neutral
2019-08-15 - Raymond James - Reinstates Market Perform
2019-07-19 113.49% Baird $120.00 Initiates Coverage On Outperform
2019-07-18 95.69% Deutsche Bank $110.00 Initiates Coverage On Buy
2019-05-23 122.38% Goldman Sachs $125.00 Assumes Buy

BPMC Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -4.29% during the next 3 months and, with a 90% probability hold a price between $49.36 and $66.04 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $51.53 $60.24 $68.95
2022-05-19 $51.47 $60.19 $68.90
2022-05-20 $51.42 $60.13 $68.85
2022-05-23 $51.37 $60.08 $68.80
2022-05-24 $51.32 $60.03 $68.74
2022-05-25 $51.27 $59.98 $68.69
2022-05-26 $51.22 $59.93 $68.64
2022-05-27 $51.16 $59.88 $68.59
2022-05-31 $51.11 $59.83 $68.54
2022-06-01 $51.06 $59.77 $68.49
2022-06-02 $51.01 $59.72 $68.44
2022-06-03 $50.96 $59.67 $68.38
2022-06-06 $50.91 $59.62 $68.33
2022-06-07 $50.86 $59.57 $68.28
2022-06-08 $50.80 $59.52 $68.23
2022-06-09 $50.75 $59.47 $68.18
2022-06-10 $50.70 $59.41 $68.13
2022-06-13 $50.65 $59.36 $68.08
2022-06-14 $50.60 $59.31 $68.02
2022-06-15 $50.55 $59.26 $67.97
2022-06-16 $50.50 $59.21 $67.92
2022-06-17 $50.44 $59.16 $67.87
2022-06-21 $50.39 $59.11 $67.82
2022-06-22 $50.34 $59.05 $67.77
2022-06-23 $50.29 $59.00 $67.71
2022-06-24 $50.24 $58.95 $67.66
2022-06-27 $50.19 $58.90 $67.61
2022-06-28 $50.13 $58.85 $67.56
2022-06-29 $50.08 $58.80 $67.51
2022-06-30 $50.03 $58.74 $67.46

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a biopharmaceutical company, develops drugs of small molecule kinase inhibitors that target genomic drivers in various cancers and rare genetic diseases. Its lead drug candidates include BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants for patients with systemic mastocytosis, a myeloproliferative disorder of the mast cells, and defined subsets of patie... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT